HLA-DRB1, major histocompatibility complex, class II, DR beta 1, 3123
N. diseases: 1018; N. variants: 185
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.360 | 6 | 32584333 | missense variant | C/G | snv | 1.3E-05 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.030 | 1.000 | 3 | 1998 | 2003 | |||||||
|
0.763 | 0.360 | 6 | 32584333 | missense variant | C/G | snv | 1.3E-05 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 1998 | 1999 | |||||||
|
0.763 | 0.360 | 6 | 32584333 | missense variant | C/G | snv | 1.3E-05 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.020 | 0.500 | 2 | 2003 | 2005 | |||||||
|
0.851 | 0.240 | 6 | 32606394 | intergenic variant | G/A;C | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.800 | 1.000 | 2 | 2007 | 2011 | ||||||||
|
0.925 | 0.120 | 6 | 32608701 | regulatory region variant | T/A;C | snv |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.800 | 1.000 | 2 | 2009 | 2013 | ||||||||
|
1.000 | 0.080 | 6 | 32584314 | missense variant | G/A;C;T | snv | 1.1E-02; 1.8E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 6 | 32584355 | missense variant | T/A;C;G | snv | 0.25; 2.7E-02; 4.7E-05; 1.6E-05; 7.6E-03 |
|
Infections; Nervous System Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||||
|
0.882 | 0.080 | 6 | 32584354 | missense variant | C/A;G;T | snv | 8.9E-03; 0.23; 1.2E-04 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 6 | 32584354 | missense variant | C/A;G;T | snv | 8.9E-03; 0.23; 1.2E-04 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 6 | 32584354 | missense variant | C/A;G;T | snv | 8.9E-03; 0.23; 1.2E-04 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 6 | 32604965 | intergenic variant | C/G | snv |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 6 | 32605248 | intergenic variant | A/G | snv |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 6 | 32583926 | intron variant | G/T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 32583926 | intron variant | G/T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.080 | 6 | 32584172 | missense variant | C/A;G;T | snv | 6.1E-04; 7.6E-03 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2000 | 2000 | |||||||
|
0.882 | 0.080 | 6 | 32584360 | missense variant | G/A;C;T | snv | 2.6E-02; 5.7E-04; 0.18; 1.3E-05 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 6 | 32584360 | missense variant | G/A;C;T | snv | 2.6E-02; 5.7E-04; 0.18; 1.3E-05 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 6 | 32584360 | missense variant | G/A;C;T | snv | 2.6E-02; 5.7E-04; 0.18; 1.3E-05 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.360 | 6 | 32584333 | missense variant | C/G | snv | 1.3E-05 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.360 | 6 | 32584333 | missense variant | C/G | snv | 1.3E-05 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2001 | 2001 | |||||||
|
0.763 | 0.360 | 6 | 32584333 | missense variant | C/G | snv | 1.3E-05 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2005 | 2005 | |||||||
|
0.763 | 0.360 | 6 | 32584333 | missense variant | C/G | snv | 1.3E-05 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.763 | 0.360 | 6 | 32584333 | missense variant | C/G | snv | 1.3E-05 |
|
Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2003 | 2003 | |||||||
|
0.763 | 0.360 | 6 | 32584333 | missense variant | C/G | snv | 1.3E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2005 | 2005 | |||||||
|
1.000 | 0.080 | 6 | 32584171 | missense variant | G/A;C;T | snv | 9.0E-04; 0.12 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2000 | 2000 |